PAM
STOK icon

Panagora Asset Management’s Stoke Therapeutics STOK Stock Holding History

Panagora Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
+58,843
New +$1.89M 0.01% 637
2025
Q1 		– Sell
-104,272
Closed -$1.15M – 1200
2024
Q4 		$1.15M Buy
+104,272
New +$1.28M 0.01% 631

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Panagora Asset Management's STOK Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 58,843 shares worth $1.93M. The stake represents 0.01% of the portfolio and ranks #637 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in STOK as recently as Q4 2024.

Panagora Asset Management first reported a position in STOK in Q4 2024 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Panagora Asset Management held 58,843 shares of Stoke Therapeutics worth $1.93M as of Q2 2026.
  • Stoke Therapeutics was a new Panagora Asset Management position in Q2 2026.
  • Stoke Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #637 holding.
  • Panagora Asset Management first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.